UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dose Finding in Oncology Trials Guided by Ordinal Toxicity Grades Using Continuous Dose Levels

Entropy (Basel, Switzerland), 2024-08, Vol.26 (8), p.687

2024

Volltextzugriff (PDF)

Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer

Journal of clinical oncology, 2017-11, Vol.35 (31), p.3601-3609

2017

Volltextzugriff (PDF)

Withaferin A inhibits breast cancer invasion and metastasis at sub‐cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation

International journal of cancer, 2011-12, Vol.129 (11), p.2744-2755

2011

Volltextzugriff (PDF)

Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index

JNCI : Journal of the National Cancer Institute, 2020-12, Vol.112 (12), p.1266-1274

2020

Volltextzugriff (PDF)

Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases

The American journal of surgical pathology, 2008-06, Vol.32 (6), p.924-927

2008

Volltextzugriff (PDF)

Escalation with overdose control using time to toxicity for cancer phase I clinical trials

PloS one, 2014-03, Vol.9 (3), p.e93070

2014

Volltextzugriff (PDF)

Comparison between continuous and discrete doses for model based designs in cancer dose finding

PloS one, 2019-01, Vol.14 (1), p.e0210139-e0210139

2019

Volltextzugriff (PDF)

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2479-2488

2008

Volltextzugriff (PDF)

Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and Inhibits Hepatocellular Carcinoma

Gastroenterology (New York, N.Y. 1943), 2010-11, Vol.139 (5), p.1762-1773.e5

2010

Volltextzugriff (PDF)

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Scientific reports, 2022-09, Vol.12 (1), p.15013-11, Article 15013

2022

Volltextzugriff (PDF)

Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma

Oral oncology, 2008-11, Vol.44 (11), p.1039-1046

2008

Volltextzugriff (PDF)

Translation of Innovative Designs Into Phase I Trials

Journal of clinical oncology, 2007-11, Vol.25 (31), p.4982-4986

2007

Volltextzugriff (PDF)

Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Scientific reports, 2022-11, Vol.12 (1), p.18731-18731, Article 18731

2022

Volltextzugriff (PDF)

Survival Impact of Adjuvant Therapy in Salivary Gland Cancers following Resection and Neck Dissection

Otolaryngology-head and neck surgery, 2019-06, Vol.160 (6), p.1048-1057

2019

Volltextzugriff (PDF)

Visualizing adverse events in clinical trials using correspondence analysis with R-package visae

BMC medical research methodology, 2021-11, Vol.21 (1), p.1-244, Article 244

2021

Volltextzugriff (PDF)

Native T1 Mapping by 3-T CMR Imaging for Characterization of Chronic Myocardial Infarctions

JACC. Cardiovascular imaging, 2015-09, Vol.8 (9), p.1019-1030

2015

Volltextzugriff (PDF)

Combined high‐intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base

Cancer, 2017-12, Vol.123 (23), p.4583-4593

2017

Volltextzugriff (PDF)

Med1 plays a critical role in the development of tamoxifen resistance

Carcinogenesis (New York), 2012-04, Vol.33 (4), p.918-930

2012

Volltextzugriff (PDF)

Two-stage design for phase I–II cancer clinical trials using continuous dose combinations of cytotoxic agents

Journal of the Royal Statistical Society Series C: Applied Statistics, 2019-01, Vol.68 (1), p.235-250

Tighiouart, Mourad

2019

Volltextzugriff (PDF)

Combinatorial effects of lapatinib and rapamycin in triple-negative breast cancer cells

Molecular cancer therapeutics, 2011-08, Vol.10 (8), p.1460-1469

2011

Volltextzugriff (PDF)

Home-based virtual reality for chronic pain: protocol for an NIH-supported randomised-controlled trial

BMJ open, 2021-06, Vol.11 (6), p.e050545-e050545

2021

Volltextzugriff (PDF)

Excellent Local Control From Radiation Therapy for High-Risk Neuroblastoma

International journal of radiation oncology, biology, physics, 2009-08, Vol.74 (5), p.1549-1554

2009

Volltextzugriff (PDF)

A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity Grades

Stats (Basel, Switzerland), 2020-09, Vol.3 (3), p.221-238

2020

Volltextzugriff (PDF)

A Pragmatic Approach Using Magnetic Resonance Imaging to Treat Ischemic Strokes of Unknown Onset Time in a Thrombolytic Trial

Stroke (1970), 2012-09, Vol.43 (9), p.2331-2335

2012

Volltextzugriff (PDF)

Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia

Cancer, 2012-11, Vol.118 (21), p.5278-5282

2012

Volltextzugriff (PDF)

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(176)

Publikationsform

Sprache

Englisch
(194)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Dose Finding in Oncology Trials Guided by Ordinal Toxicity Grades Using Continuous Dose Levels

Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer

Withaferin A inhibits breast cancer invasion and metastasis at sub‐cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation

Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index

Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases

Escalation with overdose control using time to toxicity for cancer phase I clinical trials

Comparison between continuous and discrete doses for model based designs in cancer dose finding

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells

Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and Inhibits Hepatocellular Carcinoma

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma

Translation of Innovative Designs Into Phase I Trials

Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Survival Impact of Adjuvant Therapy in Salivary Gland Cancers following Resection and Neck Dissection

Visualizing adverse events in clinical trials using correspondence analysis with R-package visae

Native T1 Mapping by 3-T CMR Imaging for Characterization of Chronic Myocardial Infarctions

Combined high‐intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base

Med1 plays a critical role in the development of tamoxifen resistance

Two-stage design for phase I–II cancer clinical trials using continuous dose combinations of cytotoxic agents

Combinatorial effects of lapatinib and rapamycin in triple-negative breast cancer cells

Home-based virtual reality for chronic pain: protocol for an NIH-supported randomised-controlled trial

Excellent Local Control From Radiation Therapy for High-Risk Neuroblastoma

A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity Grades

A Pragmatic Approach Using Magnetic Resonance Imaging to Treat Ischemic Strokes of Unknown Onset Time in a Thrombolytic Trial

Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia

Suchergebnisse filtern